glp-1 compounding news november 2025 Compounded GLP-1s: Why doctors worry and the FDA is cracking down The Risks of Compounded Semaglutide

doi: 10.1007/s40265-022-01746-8

In 1979, Richard Goodman, a researcher at the lab, removed dozens of mung bean-sized pieces of meat from the tissue surrounding the intestines of fish

However, they are not a substitute for professional medical advice, diagnosis, or treatment

The administration of GLP-1 agonists stimulates the GLP-1 receptors, increasing the insulin secretion to both oral and intravenous glucose [19]

Looking forward, the GLP-1 drugs we study (semaglutide, tirzepatide, and emerging oral formulations like orforglipron) are likely only the beginning of a new wave of chronic therapies for conditions like obesity, heart failure, and even kidney disease

If you have a BMI of 30 or more, your risk of heart disease, stroke and diabetes is four to five times higher, Dr